FDA Inspection
B Positive National Blood Services - Wilkes Barre, LLCB Positive National Blood Services - Wilkes Barre, LLC – FDA Inspection, Oct 29, 2025
Record Details
This FDA Inspection record concerns B Positive National Blood Services - Wilkes Barre, LLC, with an inspection on October 29, 2025, issued by the Philadelphia District Office, covering biologics.
- Inspection Date
- October 29, 2025
- Product Type
- Biologics
- Person
View Company Profile
ID · fa8f70a7-87f9-4a18-8398-e92acfece221
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1289072
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.60(a)Provide proper equipment to meet requirements
- 21 CFR 630.40(c)Notification w/in 8 weeks
Full citation text and observation details available on the Dashboard.
Other FDA inspections of B Positive National Blood Services - Wilkes Barre, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2023 | Not classified | Philadelphia District Office |
Other documents for B Positive National Blood Services - Wilkes Barre, LLC
- FDA Inspection 1198130 - 2023-02-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.